TY - JOUR
T1 - Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Replacement: The German Aortic Valve Registry
AU - GARY Executive Board
AU - Husser, Oliver
AU - Fujita, Buntaro
AU - Hengstenberg, Christian
AU - Frerker, Christian
AU - Beckmann, Andreas
AU - Möllmann, Helge
AU - Walther, Thomas
AU - Bekeredjian, Raffi
AU - Böhm, Michael
AU - Pellegrini, Costanza
AU - Bleiziffer, Sabine
AU - Lange, Rüdiger
AU - Mohr, Friedrich
AU - Hamm, Christian W.
AU - Bauer, Timm
AU - Ensminger, Stephan
N1 - Funding Information:
The GARY is a nonprofit nationwide registry inaugurated in July 2010 by the German Society of Cardiology and the German Society of Thoracic and Cardiovascular Surgery. The aim of GARY is to collect data on a real-world and all-comer basis for short- and long-term outcomes and to provide information on current practices of treatment in patients undergoing the complete spectrum of interventional and surgical aortic valve interventions in Germany. The protocol of GARY has been previously described in detail (7) . The responsible societies and the BQS Institute are independent organizations by virtue of their constitution both from legal and scientific points of view. GARY receives financial support in form of unrestricted grants from medical device companies (Edwards Lifesciences, Medtronic, Symetis, JenaValve Technology, Liva-Nova, St. Jude Medical, and Direct Flow Medical), the German Heart Foundation, the German Society of Cardiology, and the German Society of Thoracic and Cardiovascular Surgery, none of which have access to data or any influence on publications.
Publisher Copyright:
© 2018 American College of Cardiology Foundation
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018/3/26
Y1 - 2018/3/26
N2 - Objectives: The aims of this study were to report on the use of local anesthesia or conscious sedation (LACS) and general anesthesia in transcatheter aortic valve replacement and to analyze the impact on outcome. Background: Transcatheter aortic valve replacement can be performed in LACS or general anesthesia. Potential benefits of LACS, such as faster procedures and shorter hospital stays, need to be balanced with safety. Methods: A total of 16,543 patients from the German Aortic Valve Registry from 2011 to 2014 were analyzed, and propensity-matched analyses were performed to correct for potential selection bias. Results: LACS was used in 49% of patients (8,121 of 16,543). In hospital, LACS was associated with lower rates of low-output syndrome, respiratory failure, delirium, cardiopulmonary resuscitation, and death. There was no difference in paravalvular leakage (II+) between LACS and general anesthesia in the entire population (5% vs. 4.8%; p = 0.76) or in the matched population (3.9% vs. 4.9%, p = 0.13). The risk for prolonged intensive care unit stay (≥3 days) was significantly reduced with LACS (odds ratio: 0.82; 95% confidence interval [CI]: 0.73 to 0.92; p = 0.001). Thirty-day mortality was lower with LACS in the entire population (3.5% vs. 4.9%; hazard ratio [HR]: 0.72; 95% CI: 0.60 to 0.86; p < 0.001) and in the matched population (2.8% vs. 4.6%; HR: 0.6; 95% CI: 0.45 to 0.8; p < 0.001). However, no differences in 1-year mortality between both groups in the entire population (16.5% vs. 16.9%; HR: 0.93; 95% CI: 0.85 to 1.02; p = 0.140) and in the propensity-matched population (14.1% vs. 15.5%; HR: 0.90; 95% CI: 0.78 to 1.03; p = 0.130) were observed. Conclusions: Use of LACS in transcatheter aortic valve replacement is safe, with fewer post-procedural complications and lower early mortality, suggesting its broad application.
AB - Objectives: The aims of this study were to report on the use of local anesthesia or conscious sedation (LACS) and general anesthesia in transcatheter aortic valve replacement and to analyze the impact on outcome. Background: Transcatheter aortic valve replacement can be performed in LACS or general anesthesia. Potential benefits of LACS, such as faster procedures and shorter hospital stays, need to be balanced with safety. Methods: A total of 16,543 patients from the German Aortic Valve Registry from 2011 to 2014 were analyzed, and propensity-matched analyses were performed to correct for potential selection bias. Results: LACS was used in 49% of patients (8,121 of 16,543). In hospital, LACS was associated with lower rates of low-output syndrome, respiratory failure, delirium, cardiopulmonary resuscitation, and death. There was no difference in paravalvular leakage (II+) between LACS and general anesthesia in the entire population (5% vs. 4.8%; p = 0.76) or in the matched population (3.9% vs. 4.9%, p = 0.13). The risk for prolonged intensive care unit stay (≥3 days) was significantly reduced with LACS (odds ratio: 0.82; 95% confidence interval [CI]: 0.73 to 0.92; p = 0.001). Thirty-day mortality was lower with LACS in the entire population (3.5% vs. 4.9%; hazard ratio [HR]: 0.72; 95% CI: 0.60 to 0.86; p < 0.001) and in the matched population (2.8% vs. 4.6%; HR: 0.6; 95% CI: 0.45 to 0.8; p < 0.001). However, no differences in 1-year mortality between both groups in the entire population (16.5% vs. 16.9%; HR: 0.93; 95% CI: 0.85 to 1.02; p = 0.140) and in the propensity-matched population (14.1% vs. 15.5%; HR: 0.90; 95% CI: 0.78 to 1.03; p = 0.130) were observed. Conclusions: Use of LACS in transcatheter aortic valve replacement is safe, with fewer post-procedural complications and lower early mortality, suggesting its broad application.
UR - http://www.scopus.com/inward/record.url?scp=85045921301&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2017.12.019
DO - 10.1016/j.jcin.2017.12.019
M3 - Journal articles
C2 - 29566803
AN - SCOPUS:85045921301
SN - 1936-8798
VL - 11
SP - 567
EP - 578
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
IS - 6
ER -